Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Breakdown of the gut mucosal barrier during chronic HIV infection allows translocation of bacterial products such as lipopolysaccharides (LPS) from the gut into the circulation. Microbial translocation also occurs in inflammatory bowel disease (IBD). IBD serological markers are useful in the diagnos...

Full description

Bibliographic Details
Main Authors: Anupa Kamat, Petronela Ancuta, Richard S Blumberg, Dana Gabuzda
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-11-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2981579?pdf=render
id doaj-1f2d127f2efa45a29a2ad62fe03dc8f1
record_format Article
spelling doaj-1f2d127f2efa45a29a2ad62fe03dc8f12020-11-25T00:27:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-11-01511e1553310.1371/journal.pone.0015533Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.Anupa KamatPetronela AncutaRichard S BlumbergDana GabuzdaBreakdown of the gut mucosal barrier during chronic HIV infection allows translocation of bacterial products such as lipopolysaccharides (LPS) from the gut into the circulation. Microbial translocation also occurs in inflammatory bowel disease (IBD). IBD serological markers are useful in the diagnosis of IBD and to differentiate between Crohn's disease (CD) and ulcerative colitis (UC). Here, we evaluate detection of IBD serological markers in HIV-infected patients with advanced disease and their relationship to HIV disease markers.IBD serological markers (ASCA, pANCA, anti-OmpC, and anti-CBir1) were measured by ELISA in plasma from AIDS patients (n = 26) with low CD4 counts (<300 cells/µl) and high plasma LPS levels, and results correlated with clinical data. For meta-analysis, relevant data were abstracted from 20 articles.IBD serological markers were detected in approximately 65% of AIDS patients with evidence of microbial translocation. An antibody pattern consistent with IBD was detected in 46%; of these, 75% had a CD-like pattern. Meta-analysis of data from 20 published studies on IBD serological markers in CD, UC, and non-IBD control subjects indicated that IBD serological markers are detected more frequently in AIDS patients than in non-IBD disease controls and healthy controls, but less frequently than in CD patients. There was no association between IBD serological markers and HIV disease markers (plasma viral load and CD4 counts) in the study cohort.IBD serological markers may provide a non-invasive approach to monitor HIV-related inflammatory gut disease. Further studies to investigate their clinical significance in HIV-infected individuals are warranted.http://europepmc.org/articles/PMC2981579?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Anupa Kamat
Petronela Ancuta
Richard S Blumberg
Dana Gabuzda
spellingShingle Anupa Kamat
Petronela Ancuta
Richard S Blumberg
Dana Gabuzda
Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
PLoS ONE
author_facet Anupa Kamat
Petronela Ancuta
Richard S Blumberg
Dana Gabuzda
author_sort Anupa Kamat
title Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
title_short Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
title_full Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
title_fullStr Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
title_full_unstemmed Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.
title_sort serological markers for inflammatory bowel disease in aids patients with evidence of microbial translocation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2010-11-01
description Breakdown of the gut mucosal barrier during chronic HIV infection allows translocation of bacterial products such as lipopolysaccharides (LPS) from the gut into the circulation. Microbial translocation also occurs in inflammatory bowel disease (IBD). IBD serological markers are useful in the diagnosis of IBD and to differentiate between Crohn's disease (CD) and ulcerative colitis (UC). Here, we evaluate detection of IBD serological markers in HIV-infected patients with advanced disease and their relationship to HIV disease markers.IBD serological markers (ASCA, pANCA, anti-OmpC, and anti-CBir1) were measured by ELISA in plasma from AIDS patients (n = 26) with low CD4 counts (<300 cells/µl) and high plasma LPS levels, and results correlated with clinical data. For meta-analysis, relevant data were abstracted from 20 articles.IBD serological markers were detected in approximately 65% of AIDS patients with evidence of microbial translocation. An antibody pattern consistent with IBD was detected in 46%; of these, 75% had a CD-like pattern. Meta-analysis of data from 20 published studies on IBD serological markers in CD, UC, and non-IBD control subjects indicated that IBD serological markers are detected more frequently in AIDS patients than in non-IBD disease controls and healthy controls, but less frequently than in CD patients. There was no association between IBD serological markers and HIV disease markers (plasma viral load and CD4 counts) in the study cohort.IBD serological markers may provide a non-invasive approach to monitor HIV-related inflammatory gut disease. Further studies to investigate their clinical significance in HIV-infected individuals are warranted.
url http://europepmc.org/articles/PMC2981579?pdf=render
work_keys_str_mv AT anupakamat serologicalmarkersforinflammatoryboweldiseaseinaidspatientswithevidenceofmicrobialtranslocation
AT petronelaancuta serologicalmarkersforinflammatoryboweldiseaseinaidspatientswithevidenceofmicrobialtranslocation
AT richardsblumberg serologicalmarkersforinflammatoryboweldiseaseinaidspatientswithevidenceofmicrobialtranslocation
AT danagabuzda serologicalmarkersforinflammatoryboweldiseaseinaidspatientswithevidenceofmicrobialtranslocation
_version_ 1725341515841011712